Gene Nudelman: Can a Hemostatic Gauze Perform When Blood Clotting is Impaired?
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Can a hemostatic gauze perform when blood clotting is impaired?
Independent testing conducted at the University Hospital of Tübingen evaluated Wound Clot Advanced Bleeding Control in fresh human blood containing increasing concentrations of heparin.
The results demonstrated clot formation an000d coagulation activation in blood containing up to 3–4 IU/mL heparin, highlighting Wound Clot’s ability to support hemostasis under challenging anticoagulated conditions.
For trauma teams, surgeons, military medics, and emergency responders, every second matters – and so does confidence in the technology being used.
When clotting is compromised, performance matters.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN